In this podcast, Steve Bates, UK BioIndustry Association's CEO, discusses both the challenges and opportunities of Brexit on the UK’s biotechnology sector, and the need for strong, vital IP supported by private investment. Steve was an advisor to Tony Blair’s government and a founding member of United Life Sciences, a strategic partnership representing over 1000 life science and healthcare member companies internationally. He also sits on the Science, Industry and Translation Committee of The Royal Society.See omnystudio.com/listener for privacy information.